These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 17401459

  • 1. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma.
    Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ.
    Neoplasia; 2007 Mar; 9(3):192-9. PubMed ID: 17401459
    [Abstract] [Full Text] [Related]

  • 2. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
    Scheper MA, Nikitakis NG, Sauk JJ.
    Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
    [Abstract] [Full Text] [Related]

  • 3. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG, Scheper MA, Papanikolaou VS, Sauk JJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [Abstract] [Full Text] [Related]

  • 4. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA, Sauk JJ, Nikitakis NG.
    Anticancer Res; 2006 Jun; 26(6B):4103-13. PubMed ID: 17201121
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of Cisplatin sensitivity in squamous cell carcinoma of the head and neck transfected with a survivin antisense gene.
    Kojima H, Iida M, Yaguchi Y, Suzuki R, Hayashi N, Moriyama H, Manome Y.
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):682-5. PubMed ID: 16785416
    [Abstract] [Full Text] [Related]

  • 6. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells.
    Nikitakis NG, Hamburger AW, Sauk JJ.
    Cancer Res; 2002 Feb 15; 62(4):1004-7. PubMed ID: 11861373
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z, Khan AA, Prasad GB, Khan N, Tiwari RP, Bisen PS.
    Radiother Oncol; 2016 Feb 15; 118(2):359-68. PubMed ID: 26747757
    [Abstract] [Full Text] [Related]

  • 8. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
    Liu JR, Wu WJ, Liu SX, Zuo LF, Wang Y, Yang JZ, Nan YM.
    Pathol Res Pract; 2015 Jun 15; 211(6):426-34. PubMed ID: 25724470
    [Abstract] [Full Text] [Related]

  • 9. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
    Nikitakis NG, Hebert C, Lopes MA, Reynolds MA, Sauk JJ.
    Int J Cancer; 2002 Apr 20; 98(6):817-23. PubMed ID: 11948457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L, Wu X, Wang P, Wen T, Yu C, Wei L, Chen H.
    J Cancer Res Clin Oncol; 2015 Jun 20; 141(6):971-81. PubMed ID: 25391371
    [Abstract] [Full Text] [Related]

  • 12. Effect of nimesulide on the growth of human laryngeal squamous cell carcinoma.
    Liang Z, Liu J, Li L, Wang H, Zhao C, Jiang L, Qin G.
    Am J Otolaryngol; 2014 Jun 20; 35(2):120-9. PubMed ID: 24321753
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM, Luan XY, Lei DP, Ma XJ, Liu XX, Liu J, Pan XL.
    ORL J Otorhinolaryngol Relat Spec; 2008 Jun 20; 70(3):168-75. PubMed ID: 18391576
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.
    Bang CI, Paik SY, Sun DI, Joo YH, Kim MS.
    Ann Otol Rhinol Laryngol; 2008 Oct 20; 117(10):781-5. PubMed ID: 18998509
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.